CG Oncology CGON Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's total liabilities & equity?
- CG Oncology (CGON) reported total liabilities & equity of $1.14B in Q1 2026.
- How has CG Oncology's total liabilities & equity changed year-over-year?
- CG Oncology's total liabilities & equity increased by 55.9% year-over-year, from $728.18M to $1.14B.
- What is the long-term trend for CG Oncology's total liabilities & equity?
- Over 2 years (2023 to 2025), CG Oncology's total liabilities & equity has grown at a 99.3% compound annual growth rate (CAGR), from $199.3M to $791.59M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.